Literature DB >> 22682810

A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiation therapy for benign disease.

Mark P Little1, Marilyn Stovall, Susan A Smith, Ruth A Kleinerman.   

Abstract

PURPOSE: To assess the shape of the dose response for various cancer endpoints and modifiers by age and time. METHODS AND MATERIALS: Reanalysis of the US peptic ulcer data testing for heterogeneity of radiogenic risk by cancer endpoint (stomach, pancreas, lung, leukemia, all other).
RESULTS: There are statistically significant (P<.05) excess risks for all cancer and for lung cancer and borderline statistically significant risks for stomach cancer (P=.07), and leukemia (P=.06), with excess relative risks Gy(-1) of 0.024 (95% confidence interval [CI] 0.011, 0.039), 0.559 (95% CI 0.221, 1.021), 0.042 (95% CI -0.002, 0.119), and 1.087 (95% CI -0.018, 4.925), respectively. There is statistically significant (P=.007) excess risk of pancreatic cancer when adjusted for dose-response curvature. General downward curvature is apparent in the dose response, statistically significant (P<.05) for all cancers, pancreatic cancer, and all other cancers (ie, other than stomach, pancreas, lung, leukemia). There are indications of reduction in relative risk with increasing age at exposure (for all cancers, pancreatic cancer), but no evidence for quadratic variations in relative risk with age at exposure. If a linear-exponential dose response is used, there is no significant heterogeneity in the dose response among the 5 endpoints considered or in the speed of variation of relative risk with age at exposure. The risks are generally consistent with those observed in the Japanese atomic bomb survivors and in groups of nuclear workers.
CONCLUSIONS: There are excess risks for various malignancies in this data set. Generally there is a marked downward curvature in the dose response and significant reduction in relative risk with increasing age at exposure. The consistency of risks with those observed in the Japanese atomic bomb survivors and in groups of nuclear workers implies that there may be little sparing effect of fractionation of dose or low-dose-rate exposure. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682810      PMCID: PMC3440544          DOI: 10.1016/j.ijrobp.2012.04.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Solid tumor risks after high doses of ionizing radiation.

Authors:  Rainer K Sachs; David J Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

2.  Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.

Authors:  M P Little; H A Weiss; J D Boice; S C Darby; N E Day; C R Muirhead
Journal:  Radiat Res       Date:  1999-09       Impact factor: 2.841

3.  Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.

Authors:  M P Little
Journal:  Int J Radiat Biol       Date:  2001-04       Impact factor: 2.694

4.  Radiation exposure due to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan: solid cancer mortality in the Semipalatinsk historical cohort, 1960-1999.

Authors:  Susanne Bauer; Boris I Gusev; Ludmila M Pivina; Kazbek N Apsalikov; Bernd Grosche
Journal:  Radiat Res       Date:  2005-10       Impact factor: 2.841

5.  Active bone marrow distribution as a function of age in humans.

Authors:  M Cristy
Journal:  Phys Med Biol       Date:  1981-05       Impact factor: 3.609

6.  Joint analysis of site-specific cancer risks for the atomic bomb survivors.

Authors:  D A Pierce; D L Preston
Journal:  Radiat Res       Date:  1993-05       Impact factor: 2.841

7.  Radiation dose and second cancer risk in patients treated for cancer of the cervix.

Authors:  J D Boice; G Engholm; R A Kleinerman; M Blettner; M Stovall; H Lisco; W C Moloney; D F Austin; A Bosch; D L Cookfair; E T Krementz; H B Latourette; J A Merrill; L J Peters; M D Schulz; H H Storm; E Bjorkholm; F Pettersson; C M Janine Bell; M P Coleman; P Fraser; F E Neal; P Prior; N W Choi; T G Hislop; M Koch; N Kreiger; D Robb; D Robson; D H Thomson; H Lochmuller; D von Fournier; R Frischkorn; K E Kjørstad; A Rimpela; M H Pejovic; V P Kirn; H Stankusova; F Berrino; K Sigurdsson; G B Hutchison; B MacMahon
Journal:  Radiat Res       Date:  1988-10       Impact factor: 2.841

8.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

Authors:  D L Preston; S Kusumi; M Tomonaga; S Izumi; E Ron; A Kuramoto; N Kamada; H Dohy; T Matsuo; T ] Matsui T [corrected to Matsuo
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

Review 9.  A review of human cell radiosensitivity in vitro.

Authors:  P J Deschavanne; B Fertil
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-01       Impact factor: 7.038

10.  Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study.

Authors:  Alice J Sigurdson; Cécile M Ronckers; Ann C Mertens; Marilyn Stovall; Susan A Smith; Yan Liu; Roger L Berkow; Sue Hammond; Joseph P Neglia; Anna T Meadows; Charles A Sklar; Leslie L Robison; Peter D Inskip
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 202.731

View more
  8 in total

Review 1.  Issues in Interpreting Epidemiologic Studies of Populations Exposed to Low-Dose, High-Energy Photon Radiation.

Authors:  Ethel S Gilbert; Mark P Little; Dale L Preston; Daniel O Stram
Journal:  J Natl Cancer Inst Monogr       Date:  2020-07-01

Review 2.  Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.

Authors:  Stephanie R McKeown; Paul Hatfield; Robin J D Prestwich; Richard E Shaffer; Roger E Taylor
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

3.  Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Authors:  G M Dores; R E Curtis; F E van Leeuwen; M Stovall; P Hall; C F Lynch; S A Smith; R E Weathers; H H Storm; D C Hodgson; R A Kleinerman; H Joensuu; T B Johannesen; M Andersson; E J Holowaty; M Kaijser; E Pukkala; L Vaalavirta; S D Fossa; F Langmark; L B Travis; J F Fraumeni; B M Aleman; L M Morton; E S Gilbert
Journal:  Ann Oncol       Date:  2014-07-25       Impact factor: 32.976

4.  Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors.

Authors:  John Cologne; Jaeyoung Kim; Hiromi Sugiyama; Benjamin French; Harry M Cullings; Dale L Preston; Kiyohiko Mabuchi; Kotaro Ozasa
Journal:  Radiat Res       Date:  2019-07-29       Impact factor: 2.841

5.  Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Authors:  Ethel S Gilbert; Rochelle E Curtis; Michael Hauptmann; Ruth A Kleinerman; Charles F Lynch; Marilyn Stovall; Susan A Smith; Rita Weathers; Michael Andersson; Graça M Dores; Joseph F Fraumeni; Sophie D Fossa; Per Hall; David C Hodgson; Eric J Holowaty; Heikki Joensuu; Tom B Johannesen; Froydis Langmark; Magnus Kaijser; Eero Pukkala; Preetha Rajaraman; Hans H Storm; Leila Vaalavirta; Alexandra W van den Belt-Dusebout; Berthe M Aleman; Lois B Travis; Lindsay M Morton; Flora E van Leeuwen
Journal:  Radiat Res       Date:  2017-01-24       Impact factor: 2.841

6.  Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy.

Authors:  Benjamin J Blyth; Shizuko Kakinuma; Masaaki Sunaoshi; Yoshiko Amasaki; Shinobu Hirano-Sakairi; Kanae Ogawa; Ayana Shirakami; Yi Shang; Chizuru Tsuruoka; Mayumi Nishimura; Yoshiya Shimada
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

7.  Breast cancer occurrence after low dose radiotherapy of non-malignant disorders of the shoulder.

Authors:  Felix Zwicker; Corinna Kirchner; Peter E Huber; Jürgen Debus; Hansjörg Zwicker; Rudolf Klepper
Journal:  Sci Rep       Date:  2019-03-28       Impact factor: 4.379

8.  Risk of stomach cancer incidence in a cohort of Mayak PA workers occupationally exposed to ionizing radiation.

Authors:  Galina V Zhuntova; Tamara V Azizova; Evgeniya S Grigoryeva
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.